Consolidated Statements of Shareholders' Equity (Deficiency) - USD ($)
|
Capital Stock |
Additional Paid-in Capital |
Accumulated Other Comprehensive Income |
Accumulated Deficit |
Total |
| Beginning balance, shares at Nov. 30, 2018 |
18,252,243
|
|
|
|
|
| Beginning balance at Nov. 30, 2018 |
$ 44,327,952
|
$ 45,110,873
|
$ 284,421
|
$ (85,620,939)
|
$ 4,102,307
|
| Stock options to employees (Note 7) |
|
2,274
|
|
|
2,274
|
| Proceeds from exercise of 2018 Pre-funded Warrants (Note 9), shares |
3,673,334
|
|
|
|
|
| Proceeds from exercise of 2018 Pre-funded Warrants (Note 9) |
$ 953,549
|
(927,095)
|
|
|
26,454
|
| Net loss |
|
|
|
(3,224,449)
|
(3,224,449)
|
| Ending balance, shares at Feb. 28, 2019 |
21,925,577
|
|
|
|
|
| Ending balance at Feb. 28, 2019 |
$ 45,281,501
|
44,186,052
|
284,421
|
(88,845,388)
|
906,586
|
| Beginning balance, shares at Nov. 30, 2019 |
22,085,856
|
|
|
|
|
| Beginning balance at Nov. 30, 2019 |
$ 45,561,222
|
44,167,721
|
284,421
|
(93,705,585)
|
(3,692,221)
|
| Stock options to employees (Note 7) |
|
53,749
|
|
|
53,749
|
| Cashless exercise of 2018 Pre-Funded Warrants (Note 9), shares |
1,592,249
|
|
|
|
|
| Cashless exercise of 2018 Pre-Funded Warrants (Note 9), amount |
$ 583,190
|
(583,180)
|
|
|
0
|
| Beneficial conversion feature related to Debentures (Note 5) |
|
552,119
|
|
|
552,119
|
| Net loss |
|
|
|
(1,747,376)
|
(1,747,373)
|
| Ending balance, shares at Feb. 29, 2020 |
23,678,105
|
|
|
|
|
| Ending balance at Feb. 29, 2020 |
$ 46,144,402
|
$ 44,190,409
|
$ 284,421
|
$ (95,452,958)
|
$ (4,833,726)
|